Influence of glutathione S-transferase polymorphisms on type-2 diabetes mellitus risk

Genetics and Molecular Research

Volumn 10, Issue 4, 2011, Pages 3722-3730

  Amer, M A ^a   Ghattas, M H ^b   Abo Elmatty, D M ^c   Abou El Ela, S H ^c  

^a SINAI UNIVERSITY   (Egypt)

^b Suez Canal University Faculty of Medicine   (Egypt)

^c SUEZ CANAL UNIVERSITY   (Egypt)

Author keywords

Glutathione S transferase; Multiplex PCR; Polymorphism; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; HEMOGLOBIN A1C; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GSTM1 GENE; GSTT1 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; SMOKING; AGAR GEL ELECTROPHORESIS; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK FACTOR;

DIABETES MELLITUS, TYPE 2; ELECTROPHORESIS, AGAR GEL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84862291196     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2011.October.31.14     Document Type: Article

References (24)

1. Ada AO, Suzen SH and Iscan M (2004). Polymorphisms of cytochrome P450 1A1, glutathione S-transferases M1 and T1 in a Turkish population. Toxicol. Lett. 151: 311-315.
2. American Diabetes Association (2007). Diagnosis and classification of diabetes mellitus. Diabetes Care 30 (Suppl 1): 47.
3. Baynes JW (1991). Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412.
4. Bessa SS, Ali EM and Hamdy SM (2009). The role of glutathione S-transferase M1 and T1 gene polymorphisms and oxidative stress-related parameters in Egyptian patients with essential hypertension. Eur. J. Intern. Med. 20: 625-630.
5. Bid HK, Konwar R, Saxena M, Chaudhari P, et al. (2010). Association of glutathione S-transferase (GSTM1, T1 and P1) gene polymorphisms with type 2 diabetes mellitus in north Indian population. J. Postgrad. Med. 56: 176-181.
6. D'Alo F, Voso MT, Guidi F, Massini G, et al. (2004). Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia. Haematologica 89: 664-670.
7. Delles C, Padmanabhan S, Lee WK, Miller WH, et al. (2008). Glutathione S-transferase variants and hypertension. J. Hypertens. 26: 1343-1352.
8. Doney AS, Lee S, Leese GP, Morris AD, et al. (2005). Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study. Circulation 111: 2927-2934.
9. Douglas KT (1987). Mechanism of action of glutathione-dependent enzymes. Adv. Enzymol. Relat. Areas Mol. Biol. 59: 103-167.
10. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, et al. (2001). Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 10: 1239-1248.
11. Gorogawa S, Kajimoto Y, Umayahara Y, Kaneto H, et al. (2002). Probucol preserves pancreatic beta-cell function through reduction of oxidative stress in type 2 diabetes. Diabetes Res. Clin. Pract. 57: 1-10.
12. Gsur A, Haidinger G, Hinteregger S, Bernhofer G, et al. (2001). Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int. J. Cancer 95: 152-155.
13. Hayes JD and McLellan LI (1999). Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic. Res. 31: 273-300.
14. Hayes JD and Strange RC (2000). Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61: 154-166.
15. Hori M, Oniki K, Ueda K, Goto S, et al. (2007). Combined glutathione S-transferase T1 and M1 positive genotypes afford protection against type 2 diabetes in Japanese. Pharmacogenomics 8: 1307-1314.
16. London SJ, Yuan JM, Chung FL, Gao YT, et al. (2000). Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet 356: 724-729.
17. Maritim AC, Sanders RA and Watkins JB, III (2003). Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 17: 24-38.
18. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, et al. (1994). Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J. 300: 271-276.
19. Shaikh RS, Amir M, Masood AI, Sohail A, et al. (2010). Frequency distribution of GSTM1 and GSTT1 null allele in Pakistani population and risk of disease incidence. Environ. Toxicol. Pharmacol. 30: 76-79.
20. Shaw JE, Sicree RA and Zimmet PZ (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87: 4-14.
21. Sheehan D, Meade G, Foley VM and Dowd CA (2001). Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem. J. 360: 1-16.
22. Stephens JW, Khanolkar MP and Bain SC (2009). The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 202: 321-329.
23. Wang G, Zhang L and Li Q (2006). Genetic polymorphisms of GSTT1, GSTM1, and NQO1 genes and diabetes mellitus risk in Chinese population. Biochem. Biophys. Res. Commun. 341: 310-313.
24. Wild S, Roglic G, Green A, Sicree R, et al. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053.